THC earnings analysis
What we found in THC's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Tenet Healthcare's Q1 2026 results show a strong performance with net income of $702 million and EPS of $4.82, significantly beating estimates of $4.17. Total revenue reached $5.368 billion, marginally above expectations, with notable contributions from the Ambulatory Care segment. Despite strong revenue growth, future headwinds are anticipated due to changing payer dynamics and regulatory impacts.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Strong EPS Beat
- Reported EPS for Q1 2026 was $4.82, exceeding estimates by 15.6%.
- Revenue Growth
- Total revenue reached $5.368 billion, a 2.8% increase from $5.223 billion in Q1 2025.
- Ambulatory Care Segment Rise
- Revenue from Ambulatory Care surged 10.6% to $1.320 billion from $1.194 billion year-over-year.
- Improved Operating Cash Flow
- Net cash provided by operating activities increased to $1.641 billion, up from $815 million in Q1 2025.
- Increased Share Repurchase
- 1.346 million shares were repurchased in Q1 2026 at an average price of $236.30 per share.
- Record Cash Position
- Cash and cash equivalents increased to $2.967 billion from $2.883 billion at the end of 2025.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Changing Payer Dynamics
- Medicaid and charity admissions increased by 10.1%, indicating potential pressure from a less favorable payer mix.
- Regulatory Uncertainty
- The implementation of the One Big Beautiful Bill Act could lead to reduced Medicaid payments and increased eligibility checks.
- Patient Volume Pressure
- Anticipated adverse impacts on patient volumes and payer mix could stem from changes in healthcare coverage provisions.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $4.82
- Segment
- Hospital Operations: $4.048 billion
- Segment
- Ambulatory Care: $1.320 billion
What they said about what is next.
Management anticipates potential headwinds impacting revenues and patient volumes due to regulatory changes.
The filing reads better than the one before it.
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing THC makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever